Letter in reply: Prognostic prediction by liver tissue proteomic profiling in patients with colorectal liver metastases

Affiliations

¹ Liver Surgery & Transplantation Unit, Department of Surgery, ICMDM, Hospital Clinic, IDIBAPS, CIBERehd, Villarroel, 170, 08036, Barcelona, Spain.
² Biochemistry & Molecular Genetics Service, Hospital Clinic, IDIBAPS, CIBERehd, Villarroel, 170, 08036, Barcelona, Spain.
³ Physiological Sciences Department I, University of Barcelona, Casanova, 143, 08036, Barcelona, Spain.

Comment

Adalgiza Reyes et al. Future Oncol. 2017 Jun.

. 2017 Jun;13(13):1135-1136.

doi: 10.2217/fon-2017-0103. Epub 2017 Jun 26.

¹ Liver Surgery & Transplantation Unit, Department of Surgery, ICMDM, Hospital Clinic, IDIBAPS, CIBERehd, Villarroel, 170, 08036, Barcelona, Spain.
² Biochemistry & Molecular Genetics Service, Hospital Clinic, IDIBAPS, CIBERehd, Villarroel, 170, 08036, Barcelona, Spain.
³ Physiological Sciences Department I, University of Barcelona, Casanova, 143, 08036, Barcelona, Spain.

Abstract

In response to: S Sabour. Prognostic prediction by liver tissue proteomic profiling in patients with colorectal liver metastases; rule of thumb.

Prognostic prediction by liver tissue proteomic profiling in patients with colorectal liver metastases; rule of thumb.
Sabour S. Sabour S. Future Oncol. 2017 Jun;13(13):1133-1134. doi: 10.2217/fon-2017-0035. Epub 2017 Jun 26. Future Oncol. 2017. PMID: 28650211